Can we define and characterize the aging lower urinary tract?-ICI-RS 2015
- PMID: 28444710
- PMCID: PMC5556389
- DOI: 10.1002/nau.23035
Can we define and characterize the aging lower urinary tract?-ICI-RS 2015
Abstract
The prevalence of lower urinary tract (LUT) symptoms increases with age but the etiology is unknown. This article aims to identify research directions that clarify the basis of this association. The initial question is whether biological age is the variable of interest or a time-dependent accumulation of factors that impact on LUT function at rates that differ between individuals. In particular, the accumulation of conditions or agents due to inflammatory states or tissue ischemia is important. Much of the above has been concerned with changes to bladder function and morphology. However, the outflow tract function is also affected, in particular changes to the function of external sphincter skeletal muscle and associated sacral motor nerve control. Nocturia is a cardinal symptom of LUT dysfunction and is more prevalent with aging. Urine production is determined by diurnal changes to the production of certain hormones as well as arterial blood pressure and such diurnal rhythms are blunted in subjects with nocturia, but the causal links remain to be elucidated. Changes to the central nervous control of LUT function with age are also increasingly recognized, whether in mid-brain/brainstem regions that directly affect LUT function or in higher centers that determine psycho-social and emotional factors impinging on the LUT. In particular, the linkage between increasing white matter hyperintensities and LUT dysfunction during aging is recognized but not understood. Overall, a more rational approach is being developed to link LUT dysfunction with factors that accumulate with age, however, the precise causal pathways remain to be characterized. Neurourol. Urodynam. 36:854-858, 2017. © 2017 Wiley Periodicals, Inc.
Keywords: aging; bladder; central nervous system; ischemia; lower urinary tract symptoms; outflow tract.
© 2017 Wiley Periodicals, Inc.
Conflict of interest statement
Potential conflicts of interest: Dr. Wagg, Dr. Fry, Dr. Pontari, Dr. Andersson, and Dr. Lovick reports grants and personal fees from Allergan, Pfizer, and Astellas, outside the submitted work. Dr. Vahabi reports grants from Ferring, Dr. Valentini, and Dr. Nelson have nothing to disclose. Dr. Rademakers reports grants and personal fees from Astellas, outside the submitted work. Dr. Rosier reports grants from Allergan, Pfizer, and Astellas, grants from ONOPharma, grants from Laborie/MMS, grants from Andromeda, from Tdoc, outside the submitted work. Dr. Denys reports grants from Educational grant from Astellas, AMS, Allergan, Bard, Pfizer, Ferring, Medtronic, outside the submitted work.
References
-
- Gavrilov LA, Gavrilova NS. The biology of life span: a quantitative approach. Switzerland: Harwood Academic publishers; 1991.
-
- Austad SN. Why we age: What science is discovering about the body’s journey through life. New York: John Wiley & Sons; 1997.
-
- Takahashi N, Shishido K, Sato Y, et al. The association between severity of atherosclerosis and lower urinary tract function in male patients with lower urinary tract symptoms. Low Urin Tract Symptoms. 2012;4:9–13. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
